Clinical Trials

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02624973 2026-02-12

PETREMAC

200 enrolled

Breast Neoplasms

NCT01796197 2026-02-05

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Phase 2 Completed

23 enrolled 10 charts

Breast Neoplasms

NCT06092892 2025-12-10

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Phase 2 Recruiting

45 enrolled

Breast Neoplasms, Lymphedema

NCT00210236 2025-10-20

AXIL95

Phase 3 Terminated

625 enrolled 8 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT02883062 2025-10-16

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

67 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01841749 2025-09-12

CINNAMOME

228 enrolled 4 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06839001 2025-06-26

CRYSTAL - SIX

Phase 3 Recruiting

750 enrolled

Breast Neoplasms

NCT04585074 2025-05-15

MARRES

Active not recruiting

2,000 enrolled

Breast Neoplasms, Cystic Fibrosis

NCT06447532 2025-03-12

INFLAMMATE

Enrolling by invitation

4,500 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Inflammation

NCT02326974 2025-03-05

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

164 enrolled 19 charts

Breast Neoplasms

NCT06817954 2025-02-10

To Evaluate the Effectiveness and Safety of Mastectomy Combined With Immediate Breast Reconstruction in Breast Cancer

Phase NA Recruiting

800 enrolled

Breast Neoplasms

NCT06415032 2024-10-21

BE-Quilt

Phase NA Recruiting

296 enrolled

Breast Neoplasms, Pain

NCT01618357 2024-05-22

Pre-Operative Radiation and Veliparib for Breast Cancer

Phase 1 Completed

19 enrolled

Breast Neoplasms

NCT06425874 2024-05-22

The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery

Recruiting

1,000 enrolled

Breast Neoplasms

NCT04677075 2024-02-20

New Formula to Predict the Need for Reconstructive Coverage Following Mastectomy

74 enrolled

Breast Neoplasms

NCT06130111 2023-11-14

Secret

Unknown

170 enrolled

Breast Neoplasms

NCT06103032 2023-10-26

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

1,020 enrolled

Breast Neoplasms

NCT01234532 2022-05-03

0927GCC

Phase 2 Terminated

5 enrolled 7 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03514654 2021-05-18

MIAMI

4 enrolled

Unilateral Breast Neoplasms, Breast Neoplasms

NCT04888351 2021-05-17

IBRI

Unknown

215 enrolled

Breast Neoplasms

NCT02348684 2021-03-03

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

20 enrolled 4 charts

Breast Neoplasms

NCT04729647 2021-02-02

Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer

83 enrolled

Breast Neoplasms

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast Neoplasms

NCT01901146 2019-08-07

Lilac

Phase 3 Completed

725 enrolled 18 charts

Breast Neoplasms

NCT02125630 2019-07-31

Bone Metastasis and Surgery in Breast Cancer

460 enrolled

Breast Neoplasms

NCT02574546 2019-02-25

Markers for Predicting Risk of Breast Cancer in Women of Different Races

Withdrawn

Breast Neoplasms

NCT03762642 2018-12-06

Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients

335 enrolled

Breast Neoplasms

NCT03627442 2018-08-13

Post-op Outcomes of Enhanced Energy Delivery Dissection for Mastectomy With Immediate Breast Reconstruction

Phase NA Unknown

15 enrolled

Breast Neoplasms

NCT02061527 2018-04-24

Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

135 enrolled

Breast Neoplasms

NCT02953184 2017-12-29

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Phase 2 Unknown

160 enrolled

Breast Neoplasms

NCT02673268 2017-10-12

MARCI

Phase 2 Unknown

80 enrolled

Breast Neoplasms

NCT01167192 2016-12-30

Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer

Phase 2 Terminated

10 enrolled 8 charts

Breast Neoplasms

NCT00820690 2015-08-05

LABC

Unknown

80 enrolled

Breast Neoplasms

NCT02464774 2015-06-08

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Phase NA Unknown

464 enrolled

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

NCT00574301 2013-07-25

Percutaneous Removal and Margin Ablation for Breast Cancer

Phase 1/2 Completed

32 enrolled

Breast Neoplasms

NCT00656604 2013-03-05

Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics

30 enrolled

Breast Neoplasms

NCT00641628 2008-03-24

Nipple Areola Complex Conservation